# Blood And Organ Bank Market > Blood and Organ Bank Market Research Report By Type of Bank (Blood Bank, Organ Bank), By Storage Type (Cryopreservation, Room Temperature, Refrigerated), By Application (Medical Research, Treatment of Diseases, Emergency Transfusion), By End User (Hospitals, Research Institutions, Biopharmaceutical Companies), By Location (Hospital-Based, Independent, Mobile) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 6.81% - **2024:** $ 62.37 Billion - **2025:** $ 66.62 Billion - **2035:** $ 128.76 Billion - **Key Players:** American Red Cross (US), NHS Blood and Transplant (GB), BloodCenter of Wisconsin (US), Canadian Blood Services (CA), Australian Red Cross Blood Service (AU), National Blood Authority (AU), Serum Institute of India (IN), Korea National Red Cross (KR) **Report ID:** MRFR/HS/7553-HCR · **Pages:** 128 · **Author:** Satyendra Maurya & Rahul Gotadki · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/blood-and-organ-bank-market-9025 --- ## Market Summary ## **Blood and Organ Bank Market Overview** As per MRFR analysis, the Blood And Organ Bank Market Size was estimated at 62.37 (USD Billion) in 2024. The Blood And Organ Bank Market Industry is expected to grow from 66.62 (USD Billion) in 2025 to 120.55 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 6.81% during the forecast period (2025 - 2034). Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Key Blood and Organ Bank Market Trends Highlighted** The rising prevalence of chronic diseases, such as cancer and cardiovascular diseases, drives the demand for Blood and Organ Banks for medical procedures. Technological advancements in storage and preservation methods have led to improved viability and efficiency in blood and organ transplantation, further fueling market growth. Development of innovative stem cell therapies and regenerative medicine holds promising opportunities for the market as they offer potential treatments for conditions that previously lacked effective treatment options. Partnerships between Blood and Organ Banks and healthcare providers for seamless organ and blood transfusion services also offer growth prospects. The COVID-19 pandemic temporarily impacted the market due to restrictions on elective procedures. However, post-pandemic, there has been a surge in demand for blood and organ transplants. Growing awareness of the importance of blood and organ donation and government initiatives to promote voluntary giving contribute to the ongoing market expansion. ## **Blood and Organ Bank Market Drivers** ### **Rising Demand for Blood Transfusions** The increasing prevalence of chronic diseases, such as cancer and cardiovascular diseases, has led to a surge in demand for blood transfusions. Blood transfusions are essential for treating various medical conditions, including blood loss due to trauma, surgeries, and blood disorders. The growing number of surgeries and medical procedures worldwide has further contributed to the demand for blood and blood products. Moreover, advancements in medical technology and the development of new treatments have also increased the need for blood transfusions. The Blood and Organ Bank Market Industry is expected to witness significant growth due to the rising demand for blood transfusions. ### **Government Initiatives and Regulations** Governments worldwide are implementing various initiatives and regulations to ensure the safety and availability of blood and blood products. These initiatives include establishing blood banks, promoting blood donation drives, and setting standards for blood collection, storage, and distribution. Government regulations ensure the quality and safety of blood transfusions, which is crucial for patient well-being. The Blood and Organ Bank Market Industry is expected to benefit from supportive government policies and regulations. ### **Technological Advancements in Blood Banking** Technological advancements are transforming the blood banking industry. The development of automated blood collection systems, advanced blood storage technologies, and point-of-care testing devices has improved the efficiency and accuracy of blood banking processes. These advancements have also led to the development of new blood products and therapies, such as stem cell therapies and gene therapies. The Blood and Organ Bank Market Industry is expected to witness continued growth due to ongoing technological advancements. ## **Blood and Organ Bank Market Segment Insights** ### **Blood and Organ Bank Market Type of Bank Insights** The Blood and Organ Bank Market is segmented by Type of Bank into Blood Bank and Organ Bank. The Blood Bank segment is expected to account for a larger share of the market in 2023, owing to the increasing demand for blood transfusions due to the rising number of surgeries, accidents, and chronic diseases. According to the World Health Organization (WHO), approximately 117.4 million blood donations were collected globally in 2020. The Organ Bank segment is also expected to witness significant growth during the forecast period, driven by the rising prevalence of organ failure and the increasing number of organ transplants performed worldwide. In 2021, over 142,000 organ transplants were performed globally, according to the Observatory on Donation and Transplantation (GODT). The Blood and Organ Bank Market is highly fragmented, with numerous regional and local players operating in the market. Some of the key players in the market include Vitalant, American Red Cross, Sanquin, NHS Blood and Transplant, and OneBlood. These players are focusing on expanding their geographical presence, developing new products and technologies, and forming strategic partnerships to gain a competitive edge in the market. The Blood and Organ Bank Market is expected to witness significant growth over the next ten years, driven by the increasing demand for blood and organ transfusions, the rising prevalence of chronic diseases, and the growing number of organ transplants performed worldwide. The market is also expected to benefit from technological advancements, such as the development of new blood and organ preservation techniques and the increasing use of robotics in organ transplantation procedures. Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Blood and Organ Bank Market Storage Type Insights** The Blood and Organ Bank Market is segmented by Storage Type into Cryopreservation, Room Temperature, and Refrigerated.[cell Cryopreservation](../../../reports/cell-cryopreservation-market-21534) was the most common storage type, accounting for over 80% of the Blood and Organ Bank Market revenue in 2023. Cryopreservation involves storing blood and organs at ultra-low temperatures, typically below -130 degrees Celsius. This method is used to preserve the viability of blood and organs for extended periods, allowing for their use in transfusions and transplants. Room Temperature storage is a less common method, accounting for less than 10% of the Blood and Organ Bank Market in 2023. Room Temperature storage involves storing blood and organs at ambient temperature, typically between 4 and 25 degrees Celsius. This method is used for short-term storage of blood and organs, as it does not preserve their viability for extended periods. Refrigerated storage is another less common method, accounting for less than 5% of the Blood and Organ Bank Market in 2023. Refrigerated storage involves storing blood and organs at cold temperatures, typically between 2 and 8 degrees Celsius. This method is used for medium-term storage of blood and organs, as it can preserve their viability for longer periods than Room Temperature storage but for shorter periods than Cryopreservation. The Blood and Organ Bank Market is expected to grow steadily over the next decade, driven by increasing demand for blood transfusions and organ transplants. The market is also expected to benefit from technological advancements in storage and transportation methods, which will enable the preservation of blood and organs for longer periods. ### **Blood and Organ Bank Market Application Insights** The Blood and Organ Bank Market is segmented based on application into medical research, treatment of diseases, and emergency transfusion. The medical research segment accounted for the largest share of the market in 2023 and is projected to continue to grow at a steady pace over the forecast period. This growth is attributed to the increasing number of research studies being conducted on blood and organ transplantation, as well as the development of new technologies for preserving and storing blood and organs. The treatment of diseases segment is also expected to witness significant growth over the forecast period. This growth is driven by the rising incidence of chronic diseases, such as cancer and kidney disease, which require blood and organ transplants for treatment. The emergency transfusion segment is expected to grow at a moderate pace over the forecast period. This growth is attributed to the increasing number of accidents and trauma cases which require emergency blood transfusions. ### **Blood and Organ Bank Market End User Insights** The end user segment of the Blood and Organ Bank Market is categorized into hospitals, research institutions, and biopharmaceutical companies. Hospitals represented the dominant segment, accounting for over 60% of the market revenue in 2023. The increasing number of blood transfusions, organ transplants, and surgeries in hospitals drives this segment's growth. Research institutions contribute significantly to the market, focusing on developing new treatments and therapies for blood-related disorders and organ transplantation. Biopharmaceutical companies are involved in the production and distribution of blood-derived products and organ preservation solutions, further fueling market growth. ### **Blood and Organ Bank Market Location Insights** The location segment of the Blood and Organ Bank Market is segmented into Hospital-Based, Independent, and Mobile. The Hospital-Based segment dominated the market in 2023, with a market share of around 60%. The growth of this segment can be attributed to the increasing number of hospitals and clinics, as well as the rising demand for blood and organ transplants. The Independent segment is expected to grow at a CAGR of 7.2% during the forecast period, owing to the increasing number of private Blood and Organ Banks. The Mobile segment is expected to grow at a CAGR of 8.5% during the forecast period due to the increasing demand for mobile blood donation drives and the rising popularity of telemedicine. ### **Blood and Organ Bank Market Regional Insights** The regional segmentation of the Blood and Organ Bank Market provides insights into the performance of the market in different geographical regions. North America, Europe, Asia-Pacific (APAC), South America, and the Middle East and Africa (MEA) are the key regional segments of the Blood and Organ Bank Market. North America and Europe dominate the Blood and Organ Bank Market, collectively accounting for a significant share of the market revenue in 2023. The presence of well-established healthcare infrastructure, government initiatives, and advancements in technology contribute to the growth of the market in these regions. APAC is expected to witness the highest growth rate during the forecast period due to the increasing demand for Blood and Organ Banking services in emerging economies such as India and China. South America and MEA are also expected to witness steady growth, driven by factors such as rising healthcare expenditure and the development of healthcare infrastructure. Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **Blood and Organ Bank Market Key Players and Competitive Insights** Major players in the Blood and Organ Bank Market are constantly innovating to gain a competitive edge and stay ahead in the market. New technologies are being developed to improve the efficiency, accuracy, and speed of Blood and Organ Banking. For example, some companies are developing automated systems that can reduce the time it takes to process blood and organ samples. Other companies are developing new ways to store and preserve blood and organs, which can help to extend their shelf life and make them more accessible to patients. One of the leading companies in the Blood and Organ Bank Market industry is BioLife Solutions, Inc. (BLFS). The company is headquartered in Austin, Texas, and has operations in over 50 countries. BLFS is a provider of biopreservation products and services for the storage and transportation of cells, tissues, and organs. The company's products are used in a variety of applications, including regenerative medicine, cell therapy, and organ transplantation. BLFS is committed to providing high-quality products and services that meet the needs of its customers. A major competitor to BLFS is Thermo Fisher Scientific Inc. (TMO). The company is headquartered in Waltham, Massachusetts, and has operations in over 80 countries. TMO is a leading provider of analytical instruments, life sciences reagents, and consumables. The company's products are used in a variety of applications, including research, diagnostics, and drug discovery. TMO is committed to providing innovative products and services that help its customers accelerate their research and improve their workflows. ### **Key Companies in the Blood and Organ Bank Market Include** - Anthony Nolan - CryoCell International - [Baxter International Inc.](https://www.baxter.com/healthcare-professionals/our-products-services) - Haemonetics Corporation - Fresenius Kabi AG - Be The Match Registry - National Marrow Donor Program - [Terumo Corporation](https://www.terumo.com/business/blood-and-cell-technologies) - Grifols, S.A. - ViaCord - Sanquin - Americord - DKMS - Cord Blood Registry - FamilyCord ## **Blood and Organ Bank Market Industry Developments** The rising demand for blood and organ transplantation, the increasing prevalence of chronic diseases, and technological advancements in blood and organ preservation are key factors driving market growth. Recent news developments include the approval of new blood storage and transportation systems, such as the Hemafuse system, which allows for longer storage times and improved blood quality. Additionally, advancements in organ preservation techniques, such as machine perfusion, are extending the viability of organs for transplantation. Key market players are focusing on expanding their presence and developing innovative products to cater to the growing demand. For instance, in 2023, Thermo Fisher Scientific acquired the blood screening company Phadia to strengthen its position in the blood diagnostics market. ## **Blood and Organ Bank Market Segmentation Insights** ### **Blood and Organ Bank Market Type of Bank Outlook** - Blood Bank - Organ Bank ### **Blood and Organ Bank Market Storage Type Outlook** - Cryopreservation - Room Temperature - Refrigerated ### **Blood and Organ Bank Market Application Outlook** - Medical Research - Treatment of Diseases - Emergency Transfusion ### **Blood and Organ Bank Market End User Outlook** - Hospitals - Research Institutions - Biopharmaceutical Companies ### **Blood and Organ Bank Market Location Outlook** - Hospital-Based - Independent - Mobile ### **Blood and Organ Bank Market Regional Outlook** - North America - Europe - South America - Asia Pacific - Middle East and Africa ## Market Drivers ### Increasing Demand for Transplants The Global Blood and Organ Bank Market Industry experiences a notable surge in demand for organ transplants, driven by rising incidences of chronic diseases and an aging population. As of 2024, the market is valued at approximately 62.4 USD Billion, reflecting the urgent need for organ donations. This demand is projected to escalate, with estimates suggesting that by 2035, the market could reach 128.8 USD Billion. The increasing prevalence of conditions such as diabetes and heart disease necessitates a robust supply of organs, thereby propelling the growth of the Global Blood and Organ Bank Market Industry. ### Government Initiatives and Funding Government initiatives aimed at promoting organ donation and transplantation are pivotal in shaping the Global Blood and Organ Bank Market Industry. Various countries implement policies and funding programs to enhance public awareness and encourage donations. For instance, national campaigns and educational programs are designed to inform citizens about the importance of organ donation. Such initiatives not only increase the number of registered donors but also improve the infrastructure of blood and organ banks. As a result, these efforts are likely to foster a more robust market environment, facilitating growth and accessibility in the industry. ### Rising Awareness of Blood Donation The Global Blood and Organ Bank Market Industry is positively influenced by increasing public awareness regarding the importance of blood donation. Educational campaigns and community outreach programs have successfully highlighted the critical need for blood products, leading to higher donation rates. This heightened awareness is crucial, especially in regions where blood shortages are prevalent. As a result, blood banks are better equipped to meet the demands of healthcare systems. The ongoing efforts to promote blood donation are expected to sustain the growth trajectory of the market, ensuring a steady supply of blood products for transfusions and medical procedures. ### Emerging Markets and Global Expansion Emerging markets present substantial growth opportunities for the Global Blood and Organ Bank Market Industry. Countries with developing healthcare infrastructures are increasingly investing in blood and organ banking systems to meet local healthcare needs. This expansion is driven by rising healthcare expenditures and a growing middle class that demands better medical services. As these markets evolve, they are likely to adopt best practices from established systems, thereby enhancing their operational efficiencies. The anticipated compound annual growth rate of 6.81% from 2025 to 2035 underscores the potential for growth in these regions, contributing to the overall expansion of the industry. ### Technological Advancements in Preservation Technological innovations in [organ preservation](https://www.marketresearchfuture.com/reports/organ-preservation-market-6073) techniques significantly enhance the viability and longevity of donated organs. The Global Blood and Organ Bank Market Industry benefits from advancements such as hypothermic machine perfusion and novel preservation solutions, which improve organ quality and reduce wastage. These technologies not only extend the time frame for successful transplants but also increase the number of viable organs available for transplantation. As the industry evolves, these advancements are likely to play a crucial role in meeting the growing demand for organ transplants, thereby contributing to the overall growth of the market. ## Future Outlook The Blood and Organ Bank Market is projected to grow at a 6.81% CAGR from 2025 to 2035, driven by technological advancements, increasing demand for organ transplants, and enhanced blood collection methods. **New opportunities:** - Development of advanced biobanking technologies for personalized medicine. - Expansion of telehealth services for donor recruitment and engagement. - Implementation of AI-driven inventory management systems for blood and organ storage. By 2035, the market is expected to achieve substantial growth, driven by innovation and increased healthcare demands. ## Segment Insights ### By Application: Blood Donation (Largest) vs. Organ Transplantation (Fastest-Growing) In the Blood and Organ Bank Market, Blood Donation holds the largest market share, reflecting its critical role in healthcare systems across the globe. It is vital for emergency care, surgeries, and other medical procedures, making it an indispensable part of the healthcare continuum. [Organ Transplantation](https://www.marketresearchfuture.com/reports/organ-transplantation-market-915), while smaller in comparison, is the fastest-growing segment, driven by increasing awareness and advancements in medical technology. Blood Donation (Dominant) vs. Cell Therapy (Emerging) Blood Donation plays a dominant role in the Blood and Organ Bank Market, providing essential resources for hospitals and clinics in need of blood products for transfusions. It is supported by well-established donation drives and community involvement, leading to a steady inflow of blood products. Conversely, Cell Therapy is an emerging segment offering innovative treatment options by utilizing patients' own cells for [regenerative medicine](https://www.marketresearchfuture.com/reports/regenerative-medicine-market-2220). This segment is gaining traction due to advancements in biological research and an increase in applications for treating various diseases, positioning it as a key area for future development in the sector. ### By End Use: Hospitals (Largest) vs. Blood Banks (Fastest-Growing) In the Blood and Organ Bank Market, hospitals currently command the largest share, serving as the primary users of blood and organ storage solutions. Their extensive needs for transfusions and surgical procedures contribute significantly to their dominant market position. Blood banks also hold considerable share, focusing on blood collection and distribution, while research institutions, transplant centers, and diagnostic laboratories play important supporting roles that cater to specialized needs in blood and organ management. Hospitals (Dominant) vs. Blood Banks (Emerging) Hospitals are the dominant segment in the Blood and Organ Bank Market, characterized by extensive infrastructure and a high demand for blood and organ resources. They employ advanced storage solutions to ensure the availability of transfusable products during critical procedures. In contrast, Blood Banks represent an emerging segment, driven by innovations in blood collection and processing technologies. These facilities prioritize efficiency in collecting and preserving blood components for diverse medical needs. As advancements in storage and testing methodologies continue to evolve, Blood Banks are rapidly adapting, thus fostering growth in their operational capabilities and overall market share. ### By Product Type: Blood Products (Largest) vs. Cellular Therapies (Fastest-Growing) In the Blood and Organ Bank Market, Blood Products hold the largest market share, driven by an increasing demand for transfusions and surgical procedures. This segment is well-established, primarily used for transfusion support, and is crucial in emergency care. Following Blood Products, Cellular Therapies are gaining traction, characterized by innovative treatments like stem cell therapy, reflecting a shift towards personalized medicine. Blood Products (Dominant) vs. Cellular Therapies (Emerging) Blood Products are pivotal in the healthcare system, encompassing various components like red blood cells, platelets, and plasma. Their dominant position is underpinned by ongoing advancements in blood collection and storage technologies. In contrast, Cellular Therapies represent an emerging frontier in regenerative medicine, offering groundbreaking treatments that harness the body's own cells. They are becoming increasingly prominent due to the rise in chronic diseases and advancements in biotechnological methods, indicating a substantial shift in treatment paradigms. ### By Storage Type: Refrigerated Storage (Largest) vs. Cryogenic Storage (Fastest-Growing) Among the various storage types in the Blood and Organ Bank Market, Refrigerated Storage commands the largest share due to its widespread adoption in the preservation of blood and organs. This approach is favored for short-term storage, ensuring that temperatures remain stable enough to prolong the viability of sensitive biological materials. On the other hand, Cryogenic Storage is gaining attention as it offers an innovative solution for long-term preservation, particularly for stem cells and other cellular components. Refrigerated Storage (Dominant) vs. Cryogenic Storage (Emerging) Refrigerated Storage remains dominant in the Blood and Organ Bank Market, primarily due to its operational efficiency and effectiveness in maintaining the necessary temperature range for blood and organ viability. This method is well-established, with storage units designed for easy access and monitoring, making them indispensable in urgent medical scenarios. Conversely, Cryogenic Storage is considered an emerging segment, with advancements in technology leading to expanded applications. This method involves storing biological materials at extremely low temperatures, allowing for long-term preservation without significant cellular degradation. As the demand for advanced therapeutic solutions rises, Cryogenic Storage is expected to see substantial growth, attracting investments and innovations. ### By Service Type: Collection Services (Largest) vs. Processing Services (Fastest-Growing) In the Blood And Organ Bank Market, the market share distribution among service types reveals that Collection Services leads the segment, securing the largest share due to the critical need for blood and organ procurement in healthcare settings. Following Collection Services are Testing Services, which also hold a significant share, as accurate and timely diagnostics are imperative for ensuring the viability of collected samples. Processing Services and Transportation Services share the remainder, with Processing Services witnessing increasing demand as healthcare systems prioritize efficient processing to maximize the utility of the collected biological materials. The growth trends in the Service Type segment are driven by various factors, including advancements in medical technology and increasing public awareness regarding the importance of organ donation. Moreover, the rise of initiatives aimed at promoting blood donation is fueling the Collection Services segment. Meanwhile, Processing Services are emerging as the fastest-growing category as hospitals and clinics are investing in state-of-the-art processing techniques to enhance the overall turnaround time and quality of the services provided, thereby improving patient outcomes. Collection Services (Dominant) vs. Transportation Services (Emerging) Collection Services holds a dominant position in the Blood And Organ Bank Market, primarily driven by high demand from healthcare facilities for reliable sourcing of biological materials. This service includes various methodologies like whole blood, plasma, and organ collection that adhere to strict regulatory standards, ensuring safety and efficacy. Conversely, Transportation Services have emerged as an integral segment in ensuring the swift and safe transfer of blood and organs from collection points to processing centers and eventual recipients. The need for specialized transport systems, temperature controls, and rapid logistics has led to an increased focus on this segment, recognizing its importance in preserving the viability of biological materials throughout the transportation process. ## Regional Market Share Analysis ### North America : Market Leader in Blood Services North America continues to lead the Blood and Organ Bank market, holding a significant share of 32.0% in 2024. The region's growth is driven by advanced healthcare infrastructure, increasing demand for blood products, and stringent regulatory frameworks that ensure safety and quality. The presence of major organizations like the American Red Cross and Canadian Blood Services further bolsters market stability and innovation. The competitive landscape is characterized by a few key players, including the BloodCenter of Wisconsin and NHS Blood and Transplant. These organizations are pivotal in maintaining high standards and expanding services. The U.S. and Canada are at the forefront, leveraging technology and public awareness campaigns to enhance donor engagement and streamline operations. This focus on efficiency and safety positions North America as a benchmark for global practices. ### Europe : Growing Demand for Organ Donation Europe's Blood and Organ Bank market is witnessing a steady growth trajectory, with a market size of €15.0 million. The region is experiencing increased demand for organ transplants and blood products, driven by an aging population and rising chronic diseases. Regulatory bodies are actively promoting organ donation initiatives, which are crucial for enhancing supply and addressing shortages in various countries. Leading countries such as the UK, Germany, and France are at the forefront of this market, supported by organizations like NHS Blood and Transplant. The competitive landscape is marked by collaboration between public and private sectors to improve blood collection and distribution systems. The European Union's regulations on blood safety and quality further enhance the operational framework, ensuring that the market remains robust and responsive to healthcare needs. ### Asia-Pacific : Rapidly Expanding Market Potential The Asia-Pacific region is emerging as a significant player in the Blood and Organ Bank market, with a market size of $10.0 million. The growth is fueled by increasing healthcare investments, rising awareness about blood donation, and government initiatives aimed at improving healthcare access. Countries like India and Australia are leading the charge, focusing on enhancing their blood banking infrastructure and services to meet growing demand. Key players such as the Serum Institute of India and the Australian Red Cross Blood Service are instrumental in shaping the competitive landscape. These organizations are leveraging technology to improve donor engagement and streamline operations. The region's diverse healthcare needs and regulatory frameworks present both challenges and opportunities, making it a dynamic market for blood and organ banking. ### Middle East and Africa : Emerging Market with Challenges The Middle East and Africa region, with a market size of $5.37 million, is gradually developing its Blood and Organ Bank market. The growth is driven by increasing healthcare investments and a rising awareness of the importance of blood donation. However, challenges such as regulatory hurdles and limited infrastructure remain significant barriers to growth. Governments are focusing on improving healthcare systems to enhance blood collection and distribution. Countries like South Africa and the UAE are leading efforts to establish more efficient blood banking systems. The presence of organizations like the National Blood Authority in Australia serves as a model for improving practices in the region. Collaborative efforts between governments and NGOs are essential for addressing the existing gaps and ensuring a sustainable blood supply in the future. ## Competitive Benchmarking The Blood and Organ Bank Market is characterized by a dynamic competitive landscape, driven by increasing demand for blood and organ donations, advancements in medical technology, and a growing emphasis on patient safety. Key players such as American Red Cross (US), NHS Blood and Transplant (GB), and Serum Institute of India (IN) are strategically positioned to leverage these trends. American Red Cross (US) focuses on enhancing donor engagement through innovative digital platforms, while NHS Blood and Transplant (GB) emphasizes operational efficiency and regional partnerships to optimize blood supply chains. Serum Institute of India (IN) is expanding its global footprint by investing in international collaborations, thereby enhancing its competitive edge in the market.The market structure appears moderately fragmented, with several players competing for market share. Key business tactics include localizing manufacturing to reduce lead times and optimizing supply chains to ensure timely delivery of blood and organ products. The collective influence of these major players shapes the market dynamics, as they adopt strategies that not only enhance operational efficiency but also improve service delivery to healthcare providers. In November NHS Blood and Transplant (GB) announced a partnership with a leading technology firm to implement AI-driven inventory management systems. This strategic move is expected to enhance the accuracy of blood stock levels, thereby reducing wastage and ensuring that hospitals receive timely supplies. The integration of AI technology signifies a shift towards more data-driven decision-making processes in the sector. In October American Red Cross (US) launched a nationwide campaign aimed at increasing blood donations through targeted social media outreach and community engagement initiatives. This campaign is particularly significant as it seeks to address the ongoing challenges of maintaining adequate blood supplies, especially during peak demand periods. By leveraging social media, the organization aims to connect with younger demographics, potentially increasing donor participation. In September Serum Institute of India (IN) expanded its operations by establishing a new facility dedicated to organ preservation technologies. This facility is anticipated to enhance the company’s capabilities in organ banking, thereby positioning it as a leader in organ transplantation solutions. The establishment of this facility reflects a growing trend towards innovation in organ preservation, which is crucial for improving transplant success rates. As of December the Blood and Organ Bank Market is witnessing trends such as digitalization, sustainability, and the integration of AI technologies. Strategic alliances among key players are increasingly shaping the competitive landscape, fostering innovation and enhancing service delivery. The shift from price-based competition to a focus on technological advancements and supply chain reliability is evident, suggesting that future competitive differentiation will hinge on the ability to innovate and adapt to evolving market demands. ## Recent News & Developments The rising demand for blood and organ transplantation, the increasing prevalence of chronic diseases, and technological advancements in blood and organ preservation are key factors driving market growth. Recent news developments include the approval of new blood storage and transportation systems, such as the Hemafuse system, which allows for longer storage times and improved blood quality. Additionally, advancements in organ preservation techniques, such as machine perfusion, are extending the viability of organs for transplantation. Key market players are focusing on expanding their presence and developing innovative products to cater to the growing demand. For instance, in 2023, Thermo Fisher Scientific acquired the [blood screening](https://www.marketresearchfuture.com/reports/blood-screening-market-6899) company Phadia to strengthen its position in the blood diagnostics market. ## Report Scope | MARKET SIZE 2024 | 62.37(USD Billion) | | --- | --- | | MARKET SIZE 2025 | 66.62(USD Billion) | | MARKET SIZE 2035 | 128.76(USD Billion) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.81% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Billion | | Key Companies Profiled | American Red Cross (US), NHS Blood and Transplant (GB), BloodCenter of Wisconsin (US), Canadian Blood Services (CA), Australian Red Cross Blood Service (AU), National Blood Authority (AU), Serum Institute of India (IN), Korea National Red Cross (KR) | | Segments Covered | Application, End Use, Product Type, Storage Type | | Key Market Opportunities | Integration of advanced biobanking technologies enhances efficiency in the Blood And Organ Bank Market. | | Key Market Dynamics | Technological advancements and regulatory changes are reshaping operational efficiencies in the Blood and Organ Bank Market. | | Countries Covered | North America, Europe, APAC, South America, MEA | ## Frequently Asked Questions **Q: What is the current valuation of the Blood and Organ Bank Market?** A: The Blood and Organ Bank Market was valued at 62.37 USD Billion in 2024. **Q: What is the projected market size for the Blood and Organ Bank Market by 2035?** A: The market is projected to reach 128.76 USD Billion by 2035. **Q: What is the expected CAGR for the Blood and Organ Bank Market during the forecast period 2025 - 2035?** A: The expected CAGR for the market during 2025 - 2035 is 6.81%. **Q: Which segment had the highest valuation in 2024 within the Blood and Organ Bank Market?** A: Tissue Banking had the highest valuation at 16.87 USD Billion in 2024. **Q: What are the key applications driving the Blood and Organ Bank Market?** A: Key applications include Blood Donation, Organ Transplantation, and Blood Component Separation. **Q: Which end-use segment is projected to have the largest market share in 2035?** A: Hospitals are projected to have the largest market share, with a valuation of 38.12 USD Billion by 2035. **Q: What types of products are included in the Blood and Organ Bank Market?** A: The market includes Blood Products, Organs, Tissue Products, Cellular Therapies, and Plasma. **Q: What storage types are utilized in the Blood and Organ Bank Market?** A: Storage types include Refrigerated, Frozen, Cryogenic, and Ambient Storage. **Q: Which services are essential for the Blood and Organ Bank Market?** A: Essential services include Collection, Testing, Processing, and Transportation Services. **Q: Who are the key players in the Blood and Organ Bank Market?** A: Key players include the American Red Cross, NHS Blood and Transplant, and the Serum Institute of India. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/blood-and-organ-bank-market-9025*